Canada Cardiac Imaging Software Market Size, Share & Trends Analysis Report By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound Imaging, X-ray Imaging, Others), By Application (Diagnostic Imaging, Image Guided Treatment), By End User (Hospitals, Diagnostics Centers, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: September 01, 2026 | Author: Debashree Bora | Format:

Canada Cardiac Imaging Software Market Size

The Canada cardiac imaging software market size was valued at USD 342.00 million in 2025 and is projected to grow from USD 373.29 million in 2026 to reach USD 752.04 million by 2034, growing at a CAGR of 9.15% during the forecast period 2026–2034.

This growth is driven by advancements in diagnostic technologies, increasing prevalence of cardiovascular disease (CVD), and rising investments in healthcare infrastructure.

Download a Free Sample To learn more about this report.

Modality Insights

Magnetic resonance imaging dominates the modality segment and is expected to grow at a CAGR of 9.4% over the forecast period. MRI’s non-invasive nature and superior image quality make it indispensable for cardiac diagnostics. Innovations like 4D flow MRI and AI integration enhance diagnostic accuracy, catering to complex conditions like congenital heart defects and ischemic heart disease.

Canada Cardiac Imaging Software Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

Diagnostic imaging leads the application segment and is expected to grow at a CAGR of 8.1% during the forecast period. The increasing need for early detection of cardiac anomalies fuels this growth. The rising adoption of stress echocardiography and nuclear cardiology techniques further supports this segment’s expansion.

End-User Insights

Hospitals dominate the end-user segment and are expected to grow at a CAGR of 9.0% over the forecast period. Tertiary care facilities in urban centers are increasingly equipped with state-of-the-art imaging technologies, addressing the high patient influx. Government investments in public hospitals under initiatives like Canada’s Healthcare Infrastructure Program bolster this segment’s growth.

Canada Cardiac Imaging Software Market Share By Segments

Speak to an Analystto discuss market opportunities.

Canada Cardiac Imaging Software Market Regional Insights

The market is characterized by regional disparities in healthcare infrastructure, technological adoption, and urbanization. Key cities such as Toronto, Vancouver, Montreal, Calgary, and Ottawa play pivotal roles in driving growth.

Toronto, as Canada’s financial and healthcare hub, spearheads the adoption of cardiac imaging technologies. Institutions like the Toronto General Hospital leverage advanced systems for cutting-edge cardiac care. Collaborations with global medtech companies foster innovation and accessibility.

Vancouver’s emphasis on integrating AI into healthcare accelerates market growth. Hospitals like St. Paul’s have AI-powered imaging systems, ensuring precise diagnostics. The city’s strong focus on preventive healthcare aligns with the increasing demand for advanced cardiac imaging.

Montreal boasts a robust network of healthcare facilities specializing in cardiovascular care. Research institutions like the Montreal Heart Institute lead clinical trials for next-generation imaging solutions, driving regional advancements.

Calgary’s burgeoning healthcare infrastructure supports the adoption of innovative technologies. Partnerships between local health authorities and global companies ensure the availability of cost-effective diagnostic tools catering to the city’s diverse population.

Ottawa’s strategic focus on digital healthcare transformation enhances the adoption of cloud-based imaging solutions. The city’s advanced diagnostic centers, backed by government funding, are critical in reducing wait times and improving patient outcomes.

List of Key and Emerging Players in Canada Cardiac Imaging Software Market

FUJIFILM Holdings Corporation

Koninklijke Philips N.V

Siemens Healthineers AG

GE HealthCare

CANON MEDICAL SYSTEMS CORPORATION

NeoSoft LLC

Tempus AI Inc. (Arteys)

Pie Medical Imaging B.V. (Esaote group)

Medis Medical Imaging Systems B.V.

Circle Cardiovascular Imaging Inc.

SymphonyAI

others.

Key Industry Developments

June 2026

Sectra signed an agreement with Oak Valley Health in Canada to deploy Sectra One Cloud, providing a scalable enterprise imaging environment that can support future integration of cardiology imaging workflows.

October 2025

Canada’s National Research Council highlighted its support for Circle Cardiovascular Imaging, strengthening the development and commercialization of AI-enabled software for cardiovascular image analysis.

September 2025

Circle Cardiovascular Imaging expanded its AI-driven cardiac MRI and cardiac CT software capabilities, supporting automated image analysis, workflow standardization, and clinical decision-making.

July 2025

Canadian healthcare institutions expanded implementation of cloud-based enterprise imaging platforms capable of integrating cardiac imaging data with radiology and other clinical specialties.

June 2025

Circle Cardiovascular Imaging strengthened its cardiovascular software development and international commercialization activities from its Calgary headquarters, supporting broader availability of advanced cardiac image-analysis solutions.

Report Scope

Segmentation

By Modality 5

Computed Tomography
Magnetic Resonance Imaging
Ultrasound Imaging
X-ray Imaging
Others

By Application 2

Diagnostic Imaging
Image Guided Treatment

By End User 3

Hospitals
Diagnostics Centers
Others

Competitive Coverage FUJIFILM Holdings Corporation · Koninklijke Philips N.V · Siemens Healthineers AG · GE HealthCare · CANON MEDICAL SYSTEMS CORPORATION

Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The Canada cardiac imaging software market size was valued at USD 342.00 million in 2025 and is projected to grow from USD 373.29 million in 2026 to reach USD 752.04 million by 2034.

The canada market growth rate growing at a 9.15% from 2026 to 2034.

Rising Prevalence of Cardiovascular Diseases and Technological Advancements are the key growth factor driving the market.

Currently, Magnetic resonance imaging dominates the modality segment

About the Author

Debashree Bora

Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.